DOCUMENT TSC-2026/B64 · BLOG POST 64 · CONSUMER COMMERCE · REV. 01
D·i·l

The Red
Flags That
Make Me Walk.

Some problems kill a DTC deal. Others just scare buyers who have never run a brand. Here is how I tell them apart.

Author
Taylor Sicard
Published
June 2026
Read
14 min · ~3,400 words
Ring
I · Consumer Commerce
About the author
Taylor Sicard

Early Shopify employee who helped build and scale the Partner Program. Co-founded WIN Brands Group, scaling individual brands to eight figures and the portfolio to nine-figure revenue. Founded and sold getuptime.co to Tiny. Now advises DTC brands, Shopify app founders, and Fortune 500 commerce teams.

Full background →
Key takeaways

The genuine DTC deal killers are four: no earned demand, deteriorating cohort quality, undisclosed single-supplier fragility, and a business that only runs because the seller keeps running it. Everything else, burnout, messy ops, a bloated stack, is fixable, lowers the price, and rewards the operator who clears it.

  • Buyers overweight cosmetic problems and underweight structural ones.
  • A burned-out founder and messy warehouse are fixable in a quarter. A collapsing cohort curve is terminal.
  • This framework ran through every deal at WIN Brands Group.
Source: Taylor Sicard, Taylor Sicard Consulting · Updated June 2026

The genuine deal killers are four: no earned demand, deteriorating cohort quality, undisclosed single-supplier fragility, and a business that only runs because the seller keeps running it. That is the full list. Everything else, burnout, messy ops, concentrated catalog, bloated tech stack, is a fixable that lowers your price and rewards the operator who clears it.

I get asked what would make me walk away from a DTC brand constantly. People expect a long list. It is not. The genuine deal killers are few and specific, and most of the things buyers panic about are not on it.

The mistake I see again and again is buyers overweighting cosmetic problems while underweighting the structural ones. They walk from a brand because the founder is burned out and the warehouse is a mess, then chase a brand with beautiful operations and a cohort curve that is quietly collapsing. The first is fixable in a quarter. The second is terminal.

I ran this framework through every deal we looked at building WIN Brands Group. We were acquiring consumer brands and trying to scale them from low eight figures to the top of the range, so the cost of misreading a killer as a fixable was real. This is not a checklist I assembled after the fact. It is what kept us from getting torched on deals that looked good on the surface.

So let me separate them. Here is what actually scares me, and here is what does not.

Killers and
fixables are
not the same.

A deal killer is a problem that does not respond to capital or competence. You cannot buy your way out of it, and you cannot operate your way out of it on any reasonable timeline. A fixable problem is the opposite: it looks ugly, it lowers the price, and a capable operator clears it inside a year. The whole game is putting each problem in the right bucket before you sign.

Buyers get this backwards because the fixable problems are visible and the killers are buried. Burnout shows up in the first call. A deteriorating cohort curve hides three layers down in the data room. The visible problems get priced in. The invisible ones get you.

Most buyers have never actually operated a brand at the stage they are acquiring. They know what a healthy P&L looks like in theory, but have never felt the difference between a warehouse that runs badly because of bad process versus one that runs badly because the product is fundamentally hard to fulfill. One is a management problem. The other is a unit economics problem. Same symptom, completely different medicine. If you want a quick read before requesting the data room, the DTC Growth Scorecard places a brand at its stage and flags its binding constraint in about 90 seconds.

Platform
dependence
without a brand.

The first real killer: a business that depends entirely on a platform and has built no brand equity underneath it. A pile of revenue that exists only because of one ad account, one marketplace ranking, or one algorithm's current mood is not a brand. It is a position, and positions get taken.

The tell is the absence of earned demand. No one searches for the brand by name. There is no email base that opens and buys without a discount. There is no organic or direct traffic worth mentioning. If the only reason customers arrive is paid acquisition, then the moment costs rise or the algorithm shifts, the whole thing unwinds, and you cannot fix it by spending more. You inherit the same trap.

"A brand is the demand you do not have to pay for again. If there is none of that, you are buying a media-buying habit, not an asset."

What I look for to rule this out: a branded search volume that has grown over time, an email list that generates revenue at a reasonable discount rate (not just when you send a 40%-off blast), and some evidence that word-of-mouth exists, whether that is repeat purchase rates above category averages or organic social that converts without a budget behind it. If none of those signals show up in the unit economics data by category, I treat the business as a media-buying operation, not a brand, and price it accordingly or walk.

Platform concentration has a few flavors. Amazon dependence is the classic: a business doing 90% of revenue on Amazon with no DTC presence has very limited pricing power and zero customer relationship. Meta dependence is the next: a brand where every dollar of revenue traces back to a Meta ad account, where killing the account for a week would crater the business. Both are structurally the same problem, just different wrappers. The fix, building brand equity underneath the platform revenue, takes years, not months. A new owner cannot accelerate it much. That is what makes it a killer.

Free tool
Sorting killers from fixables is easier once you know the stage. The DTC Growth Scorecard places a brand at $1M, $5M, or $20M and flags its binding constraint in 90 seconds.
Take the scorecard →

Cohort quality
going the
wrong way.

The second killer is the one people miss most: cohort quality that is deteriorating over time. Total revenue can look flat or even up while the underlying customer behavior rots. If the cohorts you acquired this year repeat less, spend less, and churn faster than the cohorts from two years ago, the business is hollowing out from the inside. The fastest way to see it is to run the brand's CAC payback by vertical and its contribution margin by cohort: when both drift the wrong way, the decline is already priced into the future.

This matters because you are buying the future, not the past. A flat top-line built on worsening cohorts is a top-line that falls off a cliff once the acquisition spend can no longer paper over it. I treat this as close to non-negotiable. A brand whose recent cohorts are clearly worse than its older ones is a brand I price for decline or I walk. The connection between this and where a brand sits on its growth curve is the thing most buyers never properly weigh.

Here is the specific ask I make in any data room: pull repeat rate and average order value by acquisition cohort, year over year for the last three years. If the 2024 cohort looks meaningfully worse than the 2022 cohort at the same age, that is your answer. The brand is not losing customers to better competitors or higher prices, it is losing the quality of the customers it attracts. That is a product or brand signal, and it does not turn around fast.

The disguise is the dangerous part. If the brand has been ramping ad spend, total revenue holds and the CEO narrative is "we are growing." What is actually happening is that acquisition volume is masking repeat rate deterioration. Pull the spend out of the equation and the cohort chart tells the real story. I have walked from deals where the top-line was going up because I did this work and saw what was underneath. The sellers were not lying. They genuinely did not know what they had built. This also connects directly to the profitability picture: when cohorts weaken, you pay acquisition cost on a growing share of total revenue and the margin math gets worse every quarter even if revenue stays flat, which is how a brand quietly drifts below the EBITDA margin a buyer needs to see to consider it sellable.

Taylor Sicard · Consulting

Not sure if the risk you are seeing is fatal or just expensive? Let's talk it through. The form takes two minutes.

Start a conversation

The supplier
risk nobody
disclosed.

The third killer is undisclosed single-supplier fragility. A brand that sources its hero product from one factory, with no second source, no formal contract, and a relationship that runs on the founder's personal rapport, is sitting on a fault line. If that factory raises prices, gets bought, has a quality failure, or simply stops returning calls after the founder leaves, the brand's best-selling product can go dark.

What makes this a killer rather than a fixable is the word undisclosed. If a seller is upfront about supplier concentration and there is a credible path to a second source, that is a fixable I can plan around. When I find it buried, after the seller framed supply as a non-issue, it tells me two things: the risk is real, and the seller either did not understand their own business or hoped I would not look.

The practical version of this I look for: ask for all supplier contracts upfront. If the answer is "we do not really have formal contracts, we just have a great relationship," that is a flag. Dig into lead times, minimum order quantities, and whether there is an exclusivity arrangement (or not). If the hero SKU has a six-month lead time from one factory with no backup and no contract, you are one quality hold or geopolitical disruption away from no product to sell. The tariff environment in 2025 made this a much more material risk than it was three years ago, and a lot of sellers have not updated their mental model.

Disclosed supplier concentration with a plan is fine. I have acquired brands with single-supplier situations and cleared them in the first year by onboarding a second source. The cost and timeline were known going in, and we discounted the price accordingly. The version that kills deals is the one where the seller positions it as "we have a great relationship with our factory" and then you find the factory has no contract obligation to continue supplying them after a change of control. That is a material misrepresentation even when it is not intentional.

FIG. 01, KILLERS VS FIXABLESOPERATOR VIEW · 2026
ProblemBucketWhy
No earned demand
Killer
Cannot buy a brand
Cohorts decaying
Killer
Buying decline
Hidden single supplier
Killer
Product can go dark
Seller burnout
Fixable
New energy clears it
Messy ops
Fixable
Process problem

A business
that needs the
seller to stay.

The fourth killer is a brand that only works if the seller keeps working. If the founder is the brand's voice, the supplier relationship, the ad strategist, and the head of product all at once, you are not buying a transferable business. You are buying a dependency on a person who has already decided to leave. Earnouts and consulting agreements paper over this for a while, but the day they end, the thing you bought walks out the door.

The distinction matters: a founder who is involved but has built a team and documented the playbook is fine. A founder who is the single point of knowledge for everything that makes the brand work is a killer. I dig into this hard in the first 48 hours of any deal, because it is the failure mode that ambushes buyers most often after close.

The interview I find most useful: ask the founder to walk me through a normal week, hour by hour. What did they personally do that no one else can do? If the answer is "I handle all the influencer relationships," that is usually fine, those are transferable with time. If the answer is "I know the brand voice and write all the copy, and I am the only person the factory in Vietnam talks to, and I personally approve all ad creative," that is three single points of failure dressed up as one founder. No earnout structure fixes that.

Brand voice is a specific trap. If the brand's social presence, email program, and content were all built by a founder with a genuine point of view and a real audience following them personally, some of that equity is non-transferable. The audience follows the person, not the brand. Test this by looking at what percentage of the brand's organic growth or engagement came from the founder's personal content versus the brand account's own. Heavy skew toward the founder is a risk. Some founder-voice brands can be repositioned over 12–18 months if the underlying product and customer base are solid, but go in knowing the rebrand cost is real and price it in before you sign.

The problems
that are really
just discounts.

Now the other side. Seller burnout scares a lot of buyers. It does not scare me, it excites me. A burned-out founder who has stopped innovating on a brand with real demand is often the best deal on the table, because the price reflects the fatigue and the upside reflects what fresh energy and capital can do. The brand is fine. The driver is just tired.

Clunky operations are the same story. A messy warehouse, a bloated app stack, a support backlog, a chaotic spreadsheet running the whole business. These look alarming and they are entirely fixable. They are process problems, and process is what a competent operator brings. If anything, operational mess in a brand with good demand is a margin opportunity hiding in plain sight. I look at operational debt the same way I look at deferred maintenance on a property: priced correctly, it makes a good deal better. The fix costs are knowable. Build them into the model and negotiate accordingly.

The reframe

A fixable problem is a negotiating lever, not a reason to walk. Burnout, messy ops, and a concentrated catalog all lower the price and reward the operator who clears them. Save your walking for the killers.

A concentrated catalog falls in the same bucket more often than people think. A brand doing most of its revenue from three products is risky in theory, but if those products have real demand and the brand has room to extend the line, that concentration is a starting point, not a death sentence. Compare that to the killers above and the difference is obvious: one is a position you can build from, the others are foundations that are already cracking.

Tech stack debt is another one that gets over-indexed. A Shopify store running 40 apps, half of which conflict, with a custom checkout built in 2019 and a loyalty program that nobody uses. That takes six months to clean up. It is real work and it is annoying, but it is work with a clear end state. The financial stack question is more interesting: if the brand has never properly instrumented its unit economics, you may be buying a business where nobody knows what the real contribution margin is. That is actually fine if you build it correctly post-close. What is not fine is if you uncover it during diligence and the seller claims they have always run clean numbers. The discrepancy in that case is the red flag, not the underlying chaos.

Poor marketing execution is the fixable that surprises first-time buyers the most. A brand with real demand but terrible creative, no retention program, and a flat email calendar is leaving serious revenue on the table and the price usually reflects it. That is not a brand in trouble, that is a brand that has not been competently marketed. New ownership with actual execution chops can see compounding gains in the first 90 days just by tightening Klaviyo flows and deploying a real retention strategy. The demand is already there. You are just turning on the taps.

+ + + + + + + +

The red-flag
checklist from
the data room.

This is what I actually look at, and what I am looking for at each step. Use it as your pre-LOI screen before you spend real money on diligence.

FIG. 02, RED-FLAG DILIGENCE CHECKLISTWIN BRANDS METHOD · 2026
CheckWhat to pullRed flag signalVerdict
Branded search
Google Trends, Semrush brand keyword volume
Zero or flat brand search volume over 2 years
Killer
Email revenue share
ESP revenue attribution (Klaviyo, Mailchimp)
Under 20% of revenue from owned email list
Killer
Cohort repeat rate
Cohort analysis by year of acquisition, 12-month repeat
2024 cohort repeating at lower rate than 2022 cohort at same age
Killer
Supplier contracts
All active supply agreements, MOQs, lead times
No written contract for hero SKU supplier; relationship is personal
Killer
Org chart test
Ask: who does what if the founder is out for 30 days?
No clear answer for two or more critical functions
Killer
Operational state
3PL reports, SOP documentation, support ticket backlog
No SOPs, high ticket volume, messy ops
Fixable
Founder burnout
Founder tone, last product launch date, team morale
Burned out, no recent innovation, team turnover
Fixable
Catalog concentration
Revenue by SKU, top-3 SKU share of total
Over 80% from three products, no pipeline
Fixable
Tech stack debt
App audit, Shopify admin, third-party integrations
40+ apps, conflicting logic, no clear admin
Fixable
Marketing execution
Email calendar, retention flows, creative cadence
No flows, batch-and-blast emails, stale creative
Fixable

The checklist is not exhaustive, but if you run through the top five killers before you write an LOI, you save time and real money. The deals that survive an honest early screen are the ones worth doing. For the deeper financial work, the DTC benchmark card gives you the numbers to compare against by category and stage. The broader M&A context in 2026 shapes what to expect on valuation. And if you get to post-close, the integration playbook covers the work that actually decides whether the deal pays off.

+ + + + + + + +

The discipline is simple to say and hard to hold: walk from the killers, negotiate against the fixables, and never confuse the two. If you want the front end of this process, start with the 48-hour screen I run before any deal, then bring me the one that survives it.

Frequently
asked questions.

Q: What are the biggest red flags when buying a DTC brand?

The four genuine deal killers are: no earned demand (100% paid acquisition with no brand equity underneath it), deteriorating cohort quality over time, hidden single-supplier fragility, and a business that only works if the founder stays. Everything else is generally fixable by a capable operator.

Q: Is seller burnout a deal killer for a DTC acquisition?

No. Seller burnout is one of the most mispriced fixables in DTC M&A. A tired founder who has stopped innovating on a brand with real demand usually means a lower price and significant upside for fresh energy. The brand is fine. The driver is just done.

Q: How do you tell if a DTC brand's cohorts are deteriorating?

Pull repeat rate and average order value by acquisition cohort, year over year. If customers acquired in the last 12 months repurchase less frequently and spend less per order than customers acquired two or three years ago, cohort quality is declining. Total revenue can still look flat while this happens, which is what makes it dangerous.

Q: What is the difference between a deal killer and a fixable problem in DTC M&A?

A deal killer does not respond to capital or competence on any reasonable timeline. A fixable problem looks ugly, lowers the price, and a capable operator clears it inside a year. The whole diligence game is putting each problem in the right bucket before you commit.

Q: How much revenue concentration is too much for a DTC brand?

There is no hard number. A brand doing 80% of revenue from three products is not automatically a problem if those products have demonstrated demand and the brand can extend the line. Concentration only becomes a killer when combined with one of the structural issues above: no brand equity, bad cohorts, or a single supplier with no backup.

  Work with Taylor  ·  Consumer Commerce

Pressure-test the deal

Send me what scares you about the brand you are looking at. I will tell you straight whether it is a deal killer or a discount you can negotiate against.

Start a conversation More about Taylor →

Questions I keep
getting asked.

What are the biggest red flags when buying a DTC brand?
The four genuine deal killers are: no earned demand (100% paid acquisition with no brand equity underneath), deteriorating cohort quality over time, hidden single-supplier fragility, and a business that only works if the founder stays. Everything else is generally fixable by a capable operator.
Is seller burnout a deal killer for a DTC acquisition?
No. Seller burnout is one of the most mispriced fixables in DTC M&A. A tired founder who has stopped innovating on a brand with real demand usually means a lower price and significant upside for fresh energy. The brand is fine. The driver is just done.
How do you tell if a DTC brand's cohorts are deteriorating?
Pull repeat rate and average order value by acquisition cohort, year over year. If customers acquired in the last 12 months repurchase less frequently and spend less per order than customers acquired two or three years ago, cohort quality is declining. Total revenue can still look flat while this happens, which is what makes it dangerous.
What is the difference between a deal killer and a fixable problem in DTC M&A?
A deal killer does not respond to capital or competence on any reasonable timeline. A fixable problem looks ugly, lowers the price, and a capable operator clears it inside a year. The whole diligence game is putting each problem in the right bucket before you commit.
How much of a DTC brand's revenue concentration is too much?
There is no hard number. A brand doing 80% of revenue from three products is not automatically a problem if those products have demonstrated demand and the brand can extend the line. Concentration only becomes a killer when combined with one of the structural issues above: no brand equity, bad cohorts, or a single supplier with no backup.